Marcelo Wolff

Also affiliated with Universidad de Los Andes, Chile, Chinese Academy of Science South America Center for Astronomy, Fundacion Arriarán, Hospital San Borja Arriarán, University of Chile

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV”.

Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV

Scientific Reports(2023)10.1038/s41598-023-29739-x

N/A

0.241DataRank · unranked

4 citations

Sarah Samorodnitsky, Chris H. Wendt, Jason V. Baker, Gary Collins, Monica Kruk +95 more

Frequency of non-communicable diseases in people 50 years of age and older receiving HIV care in Latin America

PLoS ONE(2020)10.1371/journal.pone.0233965

N/A

0DataRank · unranked

26 citations

Yanink Caro‐Vega, Mark J Giganti, Jessica L. Castilho, Brenda Crabtree‐Ramírez, Bryan E. Shepherd +10 more

Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America

UNC Libraries(2020)10.17615/j1yq-x245

N/A

0DataRank · unranked

0 citations

Eduardo Gotuzzo, Keri N. Althoff, Pedro Cahn, James H. Willig, Peter F. Rebeiro +16 more

Tuberculosis treatment intermittency in the continuation phase and mortality in HIV-positive persons receiving antiretroviral therapy

BMC Infectious Diseases(2022)10.1186/s12879-022-07330-5

N/A

0DataRank · unranked

3 citations

Cathy A. Jenkins, Bryan E. Shepherd, Karu Jayathilake, Valdiléa G. Veloso, Gabriela Carriquiry +61 more

A Randomized Trial to Compare Dolutegravir Plus Boosted Darunavir Versus Recommended Standard of Care Antiretroviral Regimens in People With HIV-1, Whose First-line Non-nucleoside Reverse Transcriptase Inhibitor Therapy Has Failed: Final 96-week Results of the D2EFT Study

Clinical Infectious Diseases(2025)10.1093/cid/ciaf346

N/A

0DataRank · unranked

2 citations

Margaret Borok, Nnakelu Eriobu, Richard Kaplan, Nagalingeswaran Kumarasamy, Anchalee Avihingsanon +44 more